Dr. Melvin Charles Gitlin, MD

Dr. Gitlin practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Gitlin's NPI, 1760542674, was assigned on December 11, 2006. Dr. Gitlin graduated from Perelman School of Medicine - Philadelphia in 1973. Dr. Gitlin's Louisiana license number on file is 08960R.

Dr. Gitlin's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Gitlin's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Gitlin is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gitlin practices, 2 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Gitlin's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Gitlin is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Gitlin's licenses on file in 5 states: Louisiana, Florida, Oregon, Pennsylvania and New Jersey.

Dmand AI lists lower back pain and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Gitlin treats.

CMS data shows 34 Medicare services from Dr. Gitlin across 2 procedure codes in 2024, all of them office visits, for 38 Medicare patients. Medicare paid $4,512 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Dr. Gitlin in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have arthritis, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gitlin's median patient age at 67, with 62% women.

In 2024, Dr. Gitlin wrote 96 Medicare Part D claims for 14 patients. 93% of them were for generic drugs. CMS names the drug for 69 of them, across 3 drugs with 11 or more claims each, at $7,499 in total drug cost. In 2023, CMS named 52 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gitlin for performance year 2024, reported as part of a group. Dr. Gitlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gitlin as offering telehealth.

Dmand AI links 20 papers to Dr. Gitlin, published from 2009 to 2019. 2019 was the busiest year, with 3. The most frequent topics are Analgesics, Opioid, Pain, Postoperative and Pain. Dr. Gitlin has published most often in Pain Med. Dr. Gitlin's most frequent co-authors are Keith A. Candiotti, MD, Yiliam Fabiola Rodriguez, MD and Richard B. Silverman, MD.

CMS Open Payments shows 1 general payment to Dr. Gitlin from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $34.

Dmand AI lists 1 award for Dr. Gitlin, most recently CMS Stage 1 EHR in 2013.

Dr. Gitlin graduated from Perelman School of Medicine - Philadelphia in 1973. Dr. Gitlin is a member of AAPM.

Dr. Gitlin is in network with 8 carriers, including Aetna, United Healthcare and Aspirus Health Plan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.